Webcasts
In addition to the regular publications, BioPharma Dealmakers also present a series of Nature.com Webcasts that are designed to inform and educate the community about promising new science from leading companies in the field of interest. The program is developed and moderated by a Nature Publishing Group Editor, ensuring quality and involves a panel of high-quality experts that present their science and partake in a roundtable or Q&A summary session.
*Upcoming webcast*
Making a name in cancer immunotherapy
The successful approach of cancer immunotherapy—using the body’s own immune system to fight cancer—continues to push boundaries, provide new avenues for research and ultimately a new breed of candidates and technologies for the treatment of patients.
This webcast will bring a number of cancer immunotherapy companies working in the field together to present their technologies and explain how they are advancing progress within immuno-oncology. The approaches and technologies covered within the webcast will include: Bioclonics, differentiated bispecific antibody therapeutics; LAMP-Vax, a unique immunotherapy platform creating DNA-based vaccines; targeted radioimmunotherapies, antibodies delivering radioisotopes and a precision engineering platform IsoCode for predictive cell response.
The webcast will conclude with a live roundtable discussion and a Q&A session with the speakers for you the audience to put your own questions to them.
- Date: June 13, 2017
- Time: 8am PDT / 11am EDT / 4pm BST / 5pm CEST
- Price: FREE
Past webcasts
New innovations in drug delivery technology
Applicable to all diseases, it is no surprise that the market for drug delivery technologies continues to expand as innovators explore new approaches to deliver biologics, as well as cell and gene therapies.
In this webcast we will bring a number of these innovators together to present their range of diverse technologies and explain their applications in diseases such as oncology, CNS diseases and women’s health. Technologies covered within the webcast will include, digitally controlled needle-free devices, sustained and controlled transdermal delivery technology, fiber-based technology for implantable devices, targeted penetration matrix technology for non-invasive delivery and location-specific nano machines for chemotherapy payload delivery.
The webcast will conclude with a live roundtable discussion and a Q&A session with the speakers so that you the audience can put your own questions to them.
Advances in precision medicine and genomic sequencing
The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to hear the views of the speakers and to put your own questions to them.
Watch on-demand now
Innovating for ophthalmic diseases
The increased need for more effective treatments for diseases of the eye such as glaucoma, macular degeneration and dry eye, coupled with technological advances in areas such as regenerative medicine, are providing exciting opportunities for companies to develop new eye care products.
This webcast will explore some of the latest advances in the ophthalmic field through discussion with representatives from companies developing a range of innovative therapies for eye disorders, including the use of iPS cells, eye drops to deliver small-molecule drugs and complement inhibition.
The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to participate and put your own questions to the speakers.
Watch on-demand now
.jpg)
Pain targeting mechanisms
The demand for new therapeutic strategies for pain is high because established drugs have major limitations, including lack of efficacy for conditions such as neuropathic pain and the potential for abuse for opioids. In this webcast, several companies that are working to target unmet needs in pain management will present their developments, which include analgesics with novel mechanisms of action, opioids with reduced potential for abuse and medical devices.
The webcast will also include a roundtable discussion and a Q&A section to allow you to hear direct expert opinions from the speakers and contribute your own thoughts.
Watch on-demand now
Options for tackling antibiotic resistance
The growing threat of antibiotic resistance has accelerated regulatory, policy and funding initiatives over recent years, leading to a wave of new innovations in the area. In this webcast, experts from several companies in the field return to examine what is being done to tackle the impending antibiotic resistance crisis. A range of approaches include antibiotic-resistance breakers, macrocycles and other antibiotic classes for infections caused by key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus are presented by the companies.
The webcast will also include a new and extended roundtable discussion and a Q&A section to allow you to participate and ask the speakers how they intend to tackle the emerging antibiotic resistance crisis.
Watch on-demand now
Combating antibiotic resistance
With antibiotic resistance increasingly being acknowledged as a major public health threat, regulatory and policy initiatives and a growth in funding are now catalysing the revitalization of R&D in the area. In this webcast, experts from several companies in the field will examine what is being done to combat antibiotic resistance, covering approaches including antibiotic-resistance breakers, macrocycles and other antibiotic classes for infections caused by key pathogens such as Pseudomonas aeruginosa andStaphylococcus aureus.
The webcast also includes a roundtable discussion and a Q&A section to allow you to participate and contribute your own thoughts on efforts to tackle the emerging antibiotic resistance crisis.
Watch on-demand now
Developing next-generation antibody technologies
Monoclonal antibodies make up almost half of the list of the top 10 biggest-selling drugs. A wave of next-generation products — including antibody–drug conjugates (ADCs) and bispecific antibodies — promise to broaden the applicability of antibody technology further.
This webcast, featuring experts from two companies in the field, will highlight the potential of next-generation antibody technologies. By tuning in you will learn about established approaches to improve antibody production and enhance the therapeutic index of ADCs
Watch on-demand now
Innovations in Regenerative Medicine and Curative Biologics
Furthermore, genome editing technologies such as CRISPR and zinc-finger nucleases have opened up new strategies for therapeutic intervention, leading to a wave of funding into emerging companies in the area.
